• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脉络膜和脉络膜毛细血管在光动力疗法和阈下微脉冲激光治疗中心性浆液性脉络膜视网膜病变后的变化。

Choroidal and Choriocapillaris Changes after Photodynamic Therapy and Subthreshold Micropulse Laser Treatment for Central Serous Chorioretinopathy.

机构信息

Ophthalmology Clinic, Department of Medicine and Science of Ageing, "G. d'Annunzio" University Chieti-Pescara, 66100 Chieti, Italy.

Laboratory of Biostatistics, Department of Medical, Oral and Biotechnological Sciences, "G. d'Annunzio" University Chieti-Pescara, 66100 Chieti, Italy.

出版信息

Medicina (Kaunas). 2024 Oct 12;60(10):1674. doi: 10.3390/medicina60101674.

DOI:10.3390/medicina60101674
PMID:39459461
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11509465/
Abstract

: The aim of the present study is to analyze choroidal and choriocapillaris structural and functional changes in eyes affected by Central serous chorioretinopathy after Photodynamic Therapy (PDT) and Subthreshold Micropulse laser (SML) treatment. : Forty-two eyes of forty-two patients were analyzed in this observational study. Twenty-four patients underwent SML treatment, whereas eighteen patients were treated with PDT. Examinations were performed at baseline and after 3 months of treatment. Main outcome measures were: Best corrected visual acuity (BCVA), central macular thickness (CMT), central choroidal thickness (CCT), pigment epithelial detachment (PED) presence and maximum height (PEDMH), and choroidal vascularity index (CVI) measured by means of Spectralis HRA + OCT (Heidelberg Engineering, Heidelberg, Germany) Optical coherence tomography (OCT) and choriocapillaris flow voids (CCFV) measured on Optical Coherence Tomography Angiography (OCT-A) platform PLEX Elite 9000 device (Carl Zeiss Meditec Inc., Dublin, CA, USA). : Changes in BCVA were registered in both groups over time ( < 0.001). Structural changes in terms of reduced CMT and PED presence were noted in the two groups at follow-up ( < 0.001 and = 0.001, respectively). Structural and functional choroidal changes were found in the two groups with reduced CCT and CVI over time ( = 0.004 and = 0.007, respectively), with significant differences between the two groups for CVI parameter ( = 0.001). CCFV increased over time in the PDT group and decreased in the SML group. : PDT and SML are effective approaches in CSC eyes and are able to improve structural and functional parameters over time. Choroidal and choriocapillaris parameters are promising biomarkers able to monitor disease course, showing greater impact of PDT on choroid-choriocapillaris complex over time.

摘要

: 本研究旨在分析 PDT 和 SML 治疗后 CSCR 患者脉络膜和脉络膜毛细血管的结构和功能变化。 : 本观察性研究共分析了 42 例 42 只眼的患者。24 例患者行 SML 治疗,18 例患者行 PDT 治疗。基线和治疗后 3 个月进行检查。主要观察指标:最佳矫正视力(BCVA)、中心黄斑厚度(CMT)、中心脉络膜厚度(CCT)、色素上皮脱离(PED)的存在和最大高度(PEDMH)以及通过 Spectralis HRA + OCT(Heidelberg Engineering,Heidelberg,Germany)光学相干断层扫描(OCT)和脉络膜血管指数(CVI)测量、通过光学相干断层扫描血管造影(OCT-A)平台 PLEX Elite 9000 设备(Carl Zeiss Meditec Inc.,Dublin,CA,USA)测量的脉络膜毛细血管血流缺失(CCFV)。 : 两组患者的 BCVA 随时间发生变化( < 0.001)。两组患者在随访时均发现 CMT 降低和 PED 存在减少(分别为 < 0.001 和 = 0.001)。两组患者的结构和功能变化均表现为 CCT 和 CVI 随时间降低(分别为 = 0.004 和 = 0.007),两组间 CVI 参数差异有统计学意义( = 0.001)。PDT 组脉络膜毛细血管血流缺失随时间增加,SML 组减少。 : PDT 和 SML 是治疗 CSCR 的有效方法,可随时间改善结构和功能参数。脉络膜和脉络膜毛细血管参数是有前途的生物标志物,可监测疾病进程,随时间推移 PDT 对脉络膜-脉络膜毛细血管复合体的影响更大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/991e/11509465/f3116c98c9ac/medicina-60-01674-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/991e/11509465/4fcb08ee97d6/medicina-60-01674-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/991e/11509465/f3116c98c9ac/medicina-60-01674-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/991e/11509465/4fcb08ee97d6/medicina-60-01674-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/991e/11509465/f3116c98c9ac/medicina-60-01674-g002.jpg

相似文献

1
Choroidal and Choriocapillaris Changes after Photodynamic Therapy and Subthreshold Micropulse Laser Treatment for Central Serous Chorioretinopathy.脉络膜和脉络膜毛细血管在光动力疗法和阈下微脉冲激光治疗中心性浆液性脉络膜视网膜病变后的变化。
Medicina (Kaunas). 2024 Oct 12;60(10):1674. doi: 10.3390/medicina60101674.
2
Prospective evaluation of changes in choroidal vascularity index after half-dose photodynamic therapy versus micropulse laser treatment in chronic central serous chorioretinopathy.前瞻性评估半剂量光动力疗法与微脉冲激光治疗慢性中心性浆液性脉络膜视网膜病变后脉络膜血流指数的变化。
Graefes Arch Clin Exp Ophthalmol. 2020 Jun;258(6):1191-1197. doi: 10.1007/s00417-020-04619-6. Epub 2020 Mar 13.
3
Analysis of choriocapillaris perfusion and choroidal layer changes in patients with chronic central serous chorioretinopathy randomised to micropulse laser or photodynamic therapy.分析慢性中心性浆液性脉络膜视网膜病变患者脉络膜毛细血管灌注和脉络膜层变化,随机分为微脉冲激光或光动力治疗组。
Br J Ophthalmol. 2021 Apr;105(4):555-560. doi: 10.1136/bjophthalmol-2020-316076. Epub 2020 Jun 12.
4
Short term choroidal microvascular changes following photodynamic therapy in chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变光动力疗法后短期脉络膜微血管变化。
Photodiagnosis Photodyn Ther. 2023 Dec;44:103807. doi: 10.1016/j.pdpdt.2023.103807. Epub 2023 Sep 20.
5
Optical coherent tomographic angiographic pattern of the deep choroidal layer and choriocapillaris after photodynamic therapy for central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变光动力治疗后深层脉络膜层和脉络膜毛细血管的光学相干断层扫描血管造影模式
Graefes Arch Clin Exp Ophthalmol. 2019 Jul;257(7):1365-1372. doi: 10.1007/s00417-019-04318-x. Epub 2019 Apr 29.
6
Quantitative evaluation of choriocapillaris using optical coherence tomography and optical coherence tomography angiography in patients with central serous chorioretinopathy after half-dose photodynamic therapy.半剂量光动力疗法治疗中心性浆液性脉络膜视网膜病变后应用光相干断层扫描和光相干断层扫描血管成像定量评估脉络膜毛细血管。
PLoS One. 2020 Jan 13;15(1):e0227718. doi: 10.1371/journal.pone.0227718. eCollection 2020.
7
Early choriocapillaris changes after half-fluence photodynamic therapy in chronic central serous chorioretinopathy evaluated by optical coherence tomography angiography: Preliminary results.光学相干断层扫描血管造影评估半剂量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变后早期脉络膜毛细血管的变化:初步结果。
Photodiagnosis Photodyn Ther. 2018 Mar;21:375-378. doi: 10.1016/j.pdpdt.2018.01.015. Epub 2018 Feb 2.
8
Comparing Half-Dose Photodynamic Therapy with Subthreshold Micropulse Laser for the Treatment of Central Serous Chorioretinopathy.比较半剂量光动力疗法与阈下微脉冲激光治疗中心性浆液性脉络膜视网膜病变。
Ophthalmol Retina. 2024 May;8(5):490-498. doi: 10.1016/j.oret.2023.10.024. Epub 2023 Nov 11.
9
Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser.光动力疗法或微脉冲激光成功治疗慢性中心性浆液性脉络膜视网膜病变的长期随访。
Acta Ophthalmol. 2021 Nov;99(7):805-811. doi: 10.1111/aos.14775. Epub 2021 Feb 10.
10
Vascular and structural alterations of the choroid evaluated by optical coherence tomography angiography and optical coherence tomography after half-fluence photodynamic therapy in chronic central serous chorioretinopathy.在慢性中心性浆液性脉络膜视网膜病变中,通过光学相干断层扫描血管造影和光学相干断层扫描评估半量光动力治疗后脉络膜的血管和结构改变。
Graefes Arch Clin Exp Ophthalmol. 2019 May;257(5):905-912. doi: 10.1007/s00417-018-04226-6. Epub 2019 Jan 7.

引用本文的文献

1
Efficacy and safety of subthreshold micropulse laser in the treatment of central serous chorioretinopathy accompanied by choroidal hemangioma: a case report.阈下微脉冲激光治疗伴有脉络膜血管瘤的中心性浆液性脉络膜视网膜病变的疗效及安全性:病例报告
BMC Ophthalmol. 2025 Feb 11;25(1):75. doi: 10.1186/s12886-025-03898-z.

本文引用的文献

1
Central serous chorioretinopathy and the sclera: what we have learned so far.中心性浆液性脉络膜视网膜病变与巩膜:目前我们的认识。
Jpn J Ophthalmol. 2024 Sep;68(5):419-428. doi: 10.1007/s10384-024-01101-2. Epub 2024 Aug 16.
2
Subthreshold Micropulse Laser Versus Oral Spironolactone in Chronic Central Serous Chorioretinopathy: A Quasi-Randomized Controlled Trial.亚阈微脉冲激光与口服螺内酯治疗慢性中心性浆液性脉络膜视网膜病变的随机对照研究。
Transl Vis Sci Technol. 2024 Aug 1;13(8):19. doi: 10.1167/tvst.13.8.19.
3
Functional and anatomical results of subthreshold micropulse laser as rescue treatment for central serous chorioretinopathy after verteporfin shortage.
亚阈值微脉冲激光治疗维替泊芬短缺后中心性浆液性脉络膜视网膜病变的功能和解剖结果。
Photodiagnosis Photodyn Ther. 2024 Oct;49:104295. doi: 10.1016/j.pdpdt.2024.104295. Epub 2024 Jul 25.
4
Pachychoroid Spectrum Disease: Comparison of Patients with Central Serous Chorioretinopathy Complicated with Pachychoroid Neovasculopathy.厚脉络膜谱病变:伴有厚脉络膜新生血管的中心性浆液性脉络膜视网膜病变患者的比较。
Korean J Ophthalmol. 2024 Aug;38(4):304-315. doi: 10.3341/kjo.2024.0020. Epub 2024 Jul 16.
5
One-year choroidal thickness changes after photodynamic therapy for central serous chorioretinopathy evaluated by widefield optical coherence tomography.用宽视野光学相干断层扫描评估光动力疗法治疗中心性浆液性脉络膜视网膜病变后一年的脉络膜厚度变化。
Graefes Arch Clin Exp Ophthalmol. 2024 Dec;262(12):3805-3814. doi: 10.1007/s00417-024-06578-8. Epub 2024 Jul 12.
6
Clinical predictive factors and imaging biomarkers of treatment response to half dose PDT in patients with chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变患者半剂量光动力疗法治疗反应的临床预测因素和影像学生物标志物。
Photodiagnosis Photodyn Ther. 2024 Aug;48:104224. doi: 10.1016/j.pdpdt.2024.104224. Epub 2024 May 25.
7
Fluorescein versus Indocyanine Green Angiography Guided Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy.荧光素与吲哚菁绿血管造影引导下的半剂量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变
J Ophthalmic Vis Res. 2024 Mar 14;19(1):12-17. doi: 10.18502/jovr.v19i1.15420. eCollection 2024 Jan-Mar.
8
Comparisons of choroidal thickness and volume in eyes with central serous chorioretinopathy to that of control eyes determined by ultra-widefield optical coherence tomography.应用超广角光学相干断层扫描比较中心性浆液性脉络膜视网膜病变眼与对照眼脉络膜厚度和体积。
Graefes Arch Clin Exp Ophthalmol. 2024 Jul;262(7):2135-2143. doi: 10.1007/s00417-024-06409-w. Epub 2024 Feb 27.
9
Central serous chorioretinopathy: An evidence-based treatment guideline.中心性浆液性脉络膜视网膜病变:循证治疗指南。
Prog Retin Eye Res. 2024 Jul;101:101236. doi: 10.1016/j.preteyeres.2024.101236. Epub 2024 Feb 1.
10
Subthreshold laser treatment in retinal diseases: a mini review.亚阈激光治疗视网膜疾病:小型综述。
Graefes Arch Clin Exp Ophthalmol. 2024 Jul;262(7):2337-2344. doi: 10.1007/s00417-024-06382-4. Epub 2024 Jan 27.